The Anglo-Swedish drugmaker agreed in December to purchase Alexion for $39 billion. The corporate’s largest deal but provides it a specialist in rare-disease immunology so as to add to its fast-growing most cancers medicines unit and a significant COVID-19 vaccine. read more
Dunoyer’s proposed swap will enable Alexion’s Aradhana Sarin to maneuver in the other way, changing into AstraZeneca CFO within the first change to its senior management in eight years. Chief Government Pascal Soriot and Chairman Leif Johansson have been of their roles since 2012 and Dunoyer was appointed in late 2013. (https://bit.ly/3vQ1KzF)
London-listed AstraZeneca stated Sarin’s appointment is conditional upon completion of the Alexion deal, which was authorized by shareholders final month. Britain and the European Union are reviewing the deal, which gained U.S. approval in April. read more
In addition to changing into Alexion chief government, Dunoyer can even be appointed chief technique officer at AstraZeneca. He’ll go away the board however proceed to report back to Soriot.
It was unclear what position present Alexion CEO Ludwig Hantson would take after Dunoyer’s arrival.
AstraZeneca declined to remark and a consultant of United States-based Alexion couldn’t be reached for quick remark outdoors enterprise hours.
($1 = 0.7098 kilos)
Our Requirements: The Thomson Reuters Trust Principles.